BMAL1 and neoplasm: On day 28, the mice that were injected with BMAL1-depleted cells showed a significantly smaller tumor volume of 92.2 ± 17.9 mm^3, in contrast to the control group, which exhibited a larger tumor volume of 544.9 ± 34.6 mm^3 (Fig. 7H).